Understanding PDMP

Understanding Prescription Drug Monitoring Program


The PDMP monitors the prescribing and dispensing of drugs that contain controlled dangerous substances (CDS). The goal of the PDMP is to assist in the identification and prevention of prescription drug abuse. It also promotes a balanced use of prescription data that preserves the professional practice of healthcare providers and legitimate access to optimal pharmaceutical care.
The program is overseen by the Maryland Department of Health (MDH), Behavioral Health Administration (BHA).
CRISP serves as the access point for clinical providers, including prescribers, pharmacists, and other licensed healthcare practitioners for viewing filled CDS prescriptions.
If you have access to see PDMP data, you can also see PDMP data from the following states: Virginia, West Virginia, Connecticut, Arkansas.
The Behavioral Health Administration is actively working with other states to establish the mutual exchange of prescription drug monitoring program data. Please be advised that out-of-state prescriptions are matched on last name, first name, and date of birth only, which could result in improper matching in some cases. CRISP encourages providers to use discretion when interpreting interstate data.
CRISP has a strong commitment to privacy and security. All actions taken in the portal are recorded and audited by CRISP. While patients are able to opt-out of clinical information sharing; information required under state law (e.g. PDMP information) will continue to display. All eligible users accessing PDMP must review and sign an electronic Memorandum of Understanding (MOU), which can be viewed here.
Each user must have their own personal login to the system; logins and passwords may NOT be shared with others. Only patients that you have a treatment relationship with should be looked up in the portal.
If you are a pain management provider who executes Opioid Treatment Agreements, Pain Management Therapy Agreements, or similar Agreements that define the opioid prescribing relationships with your patients, and you would like to communicate this information to other prescribers at the point of care, please contact CRISP.
Maryland PDMP Facts
  • Authorized by law in 2011
  • Maryland Department of Health and
    Mental Hygiene (DHMH) program
  • Contains data on Rx controlleddangerous substances (CDS)dispensed to patients in Maryland
  • Providers get free, online accessthrough Chesapeake RegionalInformation System for our Patients(CRISP) at: www.crisphealth.org

Mandatory PDMP Use by CDS Prescribers & Pharmacists

Beginning July 1, 2018:

  • Prescribers must, with some exceptions, query and review their patient’s PDMP data prior toinitially prescribing an opioid or benzodiazepine AND at least every 90 days thereafter as long asthe course of treatment continues to include prescribing an opioid or benzodiazepine.Prescribers must also document PDMP data query and review in the patient’s medical record.
  • Pharmacists must query and review patient PDMP data prior to dispensing ANY CDS drug ifthey have a reasonable belief that a patient is seeking the drug for any purpose other than thetreatment of an existing medical condition.